Cargando…
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington’s disease
Deutetrabenazine was recently approved for the treatment of chorea in Huntington’s disease (HD) and is the first deuterated medication that has been US Food and Drug Administration (FDA)-approved for therapeutic use. In this article, we review deutetrabenazine’s drug design, pharmacokinetics, drug i...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818866/ https://www.ncbi.nlm.nih.gov/pubmed/29497277 http://dx.doi.org/10.2147/DDDT.S138828 |